Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

HBW Market Roundup: Expo West Postponed, FDA Needs International Cosmetics Meeting Input, More

Mar 03 2020

warning tape event canceled coronavirus in background running athletics red track

Related Content

OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

Jan 12 2020

Coronavirus Drives TCM Sales In China, Clouds Global Consumer Health Outlook

Feb 21 2020

US And Trading Neighbors Advocate Risk-Based, Science-Backed Cosmetics Regs

Feb 11 2020

FDA Finds Ranitidine Poses Little Risk, But Concerns Linger

Nov 04 2019

Testing Ranitidine With Too Much Heat Could Generate NDMA, FDA Says

Oct 02 2019

Related Companies

Cencora, Inc

Additional Topics

US States United States Cosmetics Dietary Supplements Ingredients Commercial Compliance FDA Manufacturing OTC Drugs Policy Regulation Coronavirus COVID-19 Consumer

More from Ingredients & Safety

More from HBW Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window